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Medical thoracoscopyAbstract Background: Differential diagnosis of pleural disease is often a lengthy process fraught
with pitfalls. Contrary to thoracocentesis and closed pleural biopsy, thoracoscopy permits biopsy
with direct visualization. Medical thoracoscopy increases the diagnostic yield in patients with pleu-
ral disease when thoracocentesis and closed pleural biopsy are non diagnostic.
Aim of the work: This study investigated diagnostic yield of medical thoracoscopy for undiag-
nosed exudative pleural effusions over one year period.
Patient and Methods: This study included 117 patients with undiagnosed exudative pleural effu-
sions. All patients were subjected to written informed consent, full history taking, clinical examina-
tion, plain chest X-ray, CT chest and tuberculin skin test. Diagnostic pleural aspiration was done
with pleural ﬂuid chemical and cytological analysis. Patients with unhelpful pleural ﬂuid analysis
underwent medical thoracoscopy.
Results: Regarding thoracoscopic pleural biopsy histopathology, out of 117 patients, 55 were
diagnosed as malignant pleural mesothelioma, 26 diagnosed as metastatic adenocarcinoma, 1 diag-
nosed as spindle cell carcinoma, 5 diagnosed as lymphoma, 5 diagnosed as tuberculosis, 1 diagnosed
898 S.A. Mohamed, M.M. Shabanas SLE, 2 diagnosed as sarcoidosis, 6 diagnosed as empyema and 16 diagnosed as chronic non spe-
ciﬁc pleurisy. There was a statistically signiﬁcant difference between the histopathological sub-
groups as regards mean value of age and smoking prevalence but there was no statistically
signiﬁcant difference as regards sex. Regarding pleural ﬂuid cytological analysis, 5 cases were
positive for malignant cells and 7 cases showed atypical mesothelial cells. Overall complication rate
after medical thoracoscopy was low with no reported mortality or major complications.
Conclusion: Medical Thoracoscopy is a valuable diagnostic tool for undiagnosed exudative
pleural effusion. It is a simple and safe procedure with low complication rate.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Medical thoracoscopy was ﬁrst introduced in 1866 by S. Gor-
don who observed the thoracic cavity with a binocular instru-
ment in a case of purulent effusion. Gordon was followed by
Hans Jacobaeus, a Swedish internist in 1910 [1].
Between 1915 and 1955 thoracoscopy was almost exclu-
sively used therapeutically in the pneumothorax treatment of
tuberculosis. In the early 1960s, thoracoscopy was used,
mainly by pulmonologists in Europe, on a much broader basis
for the diagnosis of many pleuropulmonary diseases [2].
Due to technical improvements, thoracoscopy was rediscov-
ered by thoracic surgeons at the beginning of this decade, and
renamed ‘‘surgical’’ thoracoscopy, better known as video-
assisted thoracic surgery (VATS), requiring general anesthesia
with selective end-bronchial intubation, disposable equipment,
and at least three points of entry [3,4].
Medical thoracoscopy is a minimally invasive procedure
performed by the pulmonologists in an endoscopy suite. It is
much less invasive requiring only local anesthesia with con-
scious sedation and only one or two points of entry. It also
allows for basic diagnostic (undiagnosed pleural ﬂuid or pleu-
ral thickening) and therapeutic procedures (pleurodesis) to be
performed safely and distinct from video-assisted thoracoscop-
ic surgery, an invasive procedure that uses sophisticated access
platform and multiple ports for separate viewing and working
instruments [5].
The present study investigated the diagnostic yield of med-
ical thoracoscopy for undiagnosed exudative pleural effusions
over one year period and tried to ﬁnd out its complication rate.
Subjects
Among the patients of pleural effusion who sought medical
advice at the Chest Department, Kasr Alainy Hospital during
the period from January 2012 to December 2012, a total of 117
cases were selected.
The selected patients had exudative pleural effusion with
negative or unsuccessful pleural ﬂuid analysis. Patients with
transudative pleural effusion were excluded.
Methods
All included patients were subjected to written informed con-
sent, detailed history taking, full clinical examination, routine
chemical and hematological blood analysis including liver and
kidney functions tests, complete blood count, coagulation pro-
ﬁle, plain chest X-ray (P–A and lateral view), CT chest andtuberculin skin test. Also diagnostic pleural aspiration was
done and the pleural ﬂuid was analyzed for sugar, protein,
Lactate dehydrogenase (LDH), Adenosine deaminase
(ADA), gram stain, Acid fast bacilli (AFB) smear, culture
and cytological analysis. Patients with unhelpful results of
pleural ﬂuid analysis underwent medical thoracoscopy and
pleural biopsy.Medical thoracoscopy
Equipment
Rigid thoracoscope with a cold light source was used using a
KARL-STORZ rigid thoracoscope (Fig. 1).
Technique
All cases were performed using local anesthesia (Lidocaine
2%) and analgesia using pethidine 100 mg (50 mg was given
by intramuscular injection & 50 mg was given by intravenous
injection). Lidocaine 2% was used for local anesthesia of the
skin, subcutaneous tissues, and periosteum of ribs. The needle
was advanced carefully over the superior aspect of the rib, ﬁrst
aspirating and then injecting small amounts of the lidocaine
while slowly advancing toward the pleura, till the pleural ﬂuid
was drained.
Patient’s vital signs and oxygen saturation by means of
pulse oximetry were monitored. The patient is positioned in
the lateral decubitus position, with the normal lung in the
dependent position and the affected side up with the arm rose
above the head. The puncture site is usually in the mid-axillary
zone between the fourth and sixth intercostal spaces.
The single port entry technique for thoracoscopy was used
in all cases. 1–2 cm skin incision was made with a scalpel,
which was followed by blunt dissection of intercostal muscles
until reduction of resistance is felt and the parietal pleura is
reached. Then the rigid trocar which is 8 mm in inner diameter
was introduced through the chest wall slowly and carefully.
The inner part of the trocar was then withdrawn and the tho-
racoscope was introduced inside the trocar.
The procedure included the following phases: (1) Careful
aspiration of the pleural ﬂuid; (2) Dissection of adhesions pre-
venting proper inspection of the pleural space; (3) Inspection
of the pleural space using a direct viewing telescope; and (4)
Multiple biopsy samples (usually 5–8) were obtained under
direct vision from any abnormal areas in the parietal or vis-
ceral pleura with the biopsy forceps.
After obtaining satisfactory biopsy specimens, the thoraco-
scope was removed followed by the trocar and chest tube (28-
32F) connected to under water seal was introduced in the same
Figure 1 Medical thoracoscope set.
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racoscopic pleural biopsy specimens were sent for histopathol-
ogical analysis. The chest tube was removed as soon as the
lung is clinically and radiologically re-expanded with minimal
amount of pleural ﬂuid drainage (<100 cc/24 h) [6].
Statistical analysis
Data were statistically described in terms of mean (standard
deviation (±SD), median and range, or frequencies (number
of cases) and percentages when appropriate. Comparison of
numerical variables between the study groups was done using
one way analysis of variance (ANOVA) test with posthoc mul-
tiple 2-group comparisons in normal data and Kruskal Wallis
test with posthoc multiple 2-group comparisons in non-normal
data. For comparing categorical data, Chi square (v2) test was
performed. Exact test was used instead when the expected fre-
quency is less than 5. P values less than 0.05 were considered
statistically signiﬁcant. All statistical calculations were done
using computer program SPSS (Statistical Package for the
Social Science; SPSS Inc., Chicago, IL, USA) version 15 for
Microsoft Windows.
Results
The present study included 117 patients who underwent med-
ical thoracoscopy for undiagnosed exudative pleural effusion.
They were selected from the Chest Department inpatients,
Kasr Alainy Hospital during the period from January 2012
to December 2012.Table 1 Histopathological results of thoracoscopic pleural biopsy a
Histopathological results of thoracoscopic pleural biopsy
Histopathological subgroups Count
Malignant pleural mesothelioma 55
Metastatic adenocarcinoma 26
Spindle cell carcinoma 1
Lymphoma 5
Tuberculous pleurisy 5
SLE 1
Sarcoidosis 2
Septic empyema 6
Chronic non speciﬁc pleurisy 16
Total 117On the basis of the histopathological results of the thoraco-
scopic pleural biopsy among the study population, out of 117
patients, 55 patients were diagnosed as malignant pleural
mesothelioma (47.01%), 26 patients were diagnosed as meta-
static adenocarcinoma (22.22%), 1 patient was diagnosed as
spindle cell carcinoma (0.85%), 5 patients were diagnosed as
lymphoma (4.27%), 5 patients were diagnosed as tuberculous
pleurisy (4.27%), 1 patient was diagnosed as systemic lupus
erythromatosis (0.85%), 2 patients were diagnosed as sarcoid-
osis (1.71%), 6 patients were diagnosed as septic empyema
(5.13%) and the remaining 16 patients were diagnosed as
chronic non speciﬁc pleurisy (13.68%) (Table 1).
The 16 patients who were diagnosed as chronic non speciﬁc
pleurisy were observed closely for another one year to follow
up the course of the disease in these patients. It was found that
4 patients developed MPM while the remaining 12 patients fol-
lowed a benign course. So the diagnostic yield of medical tho-
racoscopy in this study was considered 96.6% because
diagnosis was obtained in 113 out of 117 patients of the study
population & only 4 (3.41%) patients were failed to be diag-
nosed by medical thoracoscopy.
In the present study, thoracoscopic ﬁndings included (Figs.
2 and 3): (a) big pleural masses in 23 patients (22 were mesothe-
lioma and 1 case was metastatic adenocarcinoma); (b) multiple
variable sized nodules in 67 patients (18 were mesothelioma, 25
were metastatic adenocarcinoma, 2 cases were sarcoidosis, 5
cases were tuberculous pleurisy, 5 cases were lymphoma, 11
were chronic non speciﬁc pleurisy); (c) septic pyogenic mem-
branes with extensive adhesions in 7 patients (6 were septic
empyema and 1 case was chronic non speciﬁc pleurisy); (d) dif-
fuse pleural thickening in 17 patients (14 were mesothelioma, 2mong the study population.
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Figure 2 Main Thoracoscopic Findings.
Figure 3 Thoracoscopic pictures of some pleural abnormalities: (A) Big pleural masses in cases of MPM. (B) Diffuse thickening of the
costal pleura mainly in cases of MPM. (C) Different forms of adhesions mainly in cases of empyema. (D) Multiple variable sized pleural
nodules mainly in cases of tuberculosis, metastatic adenocarcinoma and MPM.
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smooth apparently healthy pleura in 3 patients (1 case was
mesothelioma and 2 cases were chronic non speciﬁc pleurisy).
The age of the study population ranged from 21 to 77 years
old with a mean value of 52.03 and ±SD 13.81. There was a
statistically signiﬁcant difference as regards the mean value
of the age among the histopathological subgroups of the study
population with P-value of 0.000. The signiﬁcant difference
was between the two histopathological subgroups with the
lowest mean value of age (lymphoma and septic empyema)
and the three histopathological subgroups with the highest
mean value of age (MPM, metastatic adenocarcinoma and
chronic non speciﬁc pleurisy) (Table 2).
The present study included 62 female patients with a per-
cent of 53% and 55 male patients with a percent of 47%. There
was no statistically signiﬁcant difference between the different
histopathological subgroups of the study population as
regards sex distribution (Table 3).
There was a statistically signiﬁcant difference between the
different histopathological subgroups of the study population
as regards smoking prevalence. There was higher percentageTable 2 Mean age of the histopathological subgroups of the
study population.
Histopathological subgroups Count Mean age ± SD
Malignant pleural mesothelioma 55 54.71 ± 12.38
Metastatic adenocarcinoma 26 56.04 ± 13.66
Spindle cell carcinoma 1 34.00
Lymphoma 5 31.00 ± 14.16
Tuberculous pleurisy 5 49.00 ± 11.31
SLE 1 43.00
Sarcoidosis 2 40.50 ± 4.95
Septic empyema 6 31.83 ± 9.37
Chronic non speciﬁc pleurisy 16 54.56 ± 8.49
Total 117 52.03 ± 13.81
P-value = 0.000*
Statistical signiﬁcance Signiﬁcant
* P-value < 0.05 means statistically signiﬁcant.
Table 3 Sex distribution among histopathological subgroups of the
Histopathological Subgroups
Chronic non
speciﬁc pleurisy
Spindle cell
carcinoma
Lymphoma MPM
Female Count 9 1 2 29
% within
histopathology
subgroup
56.3 100 40.0 52.7
Male Count 7 0 3 26
within
histopathology
subgroup
43.8 0.0 60.0 47.3
Total Count 16 1 5 55
% within
histopathology
subgroup
100 100 100.0 100.0
P-value =
Statistical signiﬁcanceof smokers in relation to non smokers in the malignant
subgroups including MPM, metastatic adenocarcinoma and
lymphoma (Table 4).
As regards the chemical analysis of the pleural ﬂuid, there
was a statistically signiﬁcant difference between the histopa-
thological subgroups of the study population as regards the
mean values of LDH, glucose and ADA. As regards the mean
value of LDH and glucose, the signiﬁcant difference was
between the subgroup of septic empyema and subgroups of
chronic non speciﬁc pleurisy, lymphoma, MPM and metastatic
adenocarcinoma. As regards the mean value of ADA the signif-
icant difference was between tuberculous pleurisy subgroup
and subgroups of MPM, metastatic adenocarcinoma, chronic
non speciﬁc pleurisy and septic empyema (Table 5).
On the basis of pleural ﬂuid cytological analysis, 5 cases
only were positive for malignant cells and then proved to be
MPM by thoracoscopic pleural biopsy and only 7 cases
showed atypical mesothelial cell and then proved to be
MPM (6 cases) and tuberculous pleurisy (1 case). The remain-
ing 105 cases showed exudative effusion with no evidence of
malignant cells (Table 6).
In the present study, there was no reported mortality and
no observed major complications. Only 6 patients had minor
complications like prolonged air leak (1 patient), subcutaneous
emphysema (2 patients), wound infection (1 patient) and
empyema (2 patients).
Discussion
Even after extensive diagnostic evaluation of a patient with
pleural effusion, the etiology often remains unclear. Pleural
ﬂuid studies and blind pleural biopsy have their own limita-
tions. It is in this context that pleuroscopy or thoracoscopy
becomes an important investigation so that the pleural surface
can be visualized and representative sample can easily be
picked. The concept of medical thoracoscopy is a simpliﬁca-
tion of VATS, as it is done under conscious sedation through
a single port by chest physicians [7].
The 2000 American Thoracic Society statement on manage-
ment of malignant pleural effusions stated that indications forstudy population.
Metastatic
adenocarcinoma
Sarcoidosis Septic
empyema
SLE T.B. pleurisy Total
17 1 0 1 2 62
65.4 50.0 0.0 100.0 40.0 53.0
9 1 6 0 3 55
34.6 50.0 100.0 0.0 60.0 47.0
26 2 6 1 5 117
100.0 100.0 100.0 100.0 100.0 100.0
0.208
Not signiﬁcant
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effusions of unknown cause’’, among others, and that in cases
of undiagnosed exudative effusions with a high clinical suspi-
cion for malignancy, some clinicians may proceed directly to
thoracoscopy if the facilities for medical thoracoscopy are
available [8,9].
Several studies suggested that medical thoracoscopy
increases the diagnostic yield in patients with benign and
malignant pleural disease when thoracocentesis is non diagnos-
tic [10,11].
The following is a one year prospective study of the diag-
nostic yield of medical thoracoscopy, carried out on 117
patients with undiagnosed exudative pleural effusions, in the
Chest Department, Faculty of Medicine, Cairo University dur-
ing the period from January 2012 to December 2012. Also the
present study tried to ﬁnd out the complication rate associated
with medical thoracoscopy.
In the present study, the histopathological results of tho-
racoscopic pleural biopsy among the study population,
revealed MPM in 47.01% (55 patients), metastatic adenocarci-
noma in 22.22% (26 patients), spindle cell carcinoma in 0.85%
(1 patient), lymphoma in 4.27% (5 patients), tuberculous pleu-
risy in 4.27% (5 patients), SLE in 0.85% (1 patient), sarcoido-
sis in 1.71% (2 patients), septic empyema in 5.13% (6 patients)
and chronic non speciﬁc pleurisy was diagnosed in 13.68% (16
patients).
By comparing the results of the present study to other sev-
eral studies which evaluated the diagnostic role of medical tho-
racoscopy in pleural effusion, it was found that the present
study disagreed with the study performed by Jiang et al. [12]
who showed pleural metastases in 37.8%, primary pleural
mesothelioma in only 18.4%, tuberculous pleurisy in 21.6%,
non speciﬁc inﬂammation in 9.5% & empyema in 8.0%.
Again the present study disagreed with Wang et al. [13] who
found that out of 27 patients who underwent medical thora-
coscopy, 15 patients had malignancy among them, 12 patients
had metastatic carcinoma, 2 patients only mesothelioma and 1
patient has non-Hodgkin’s lymphoma. Also they found tuber-
culous pleurisy in 22% (6 patients), nonspeciﬁc inﬂammation
in 7% (2 patients), septic empyema in 4% (1 patient) and nor-
mal pleura in 4% (1 patient). Only 2 (7%) patients could not
get deﬁnite diagnosis. Diagnostic efﬁciency of medical thora-
coscopy in this study was 93%.
In the present study, the 16 patients who were diagnosed as
chronic non speciﬁc pleurisy were observed closely for another
one year to follow up the course of the disease in these
patients. It was found that 4 patients developed malignancy
(MPM) while the remaining 12 patients followed a benign
course. So the diagnostic yield of medical thoracoscopy in this
study was considered 96.6% because diagnosis was obtained in
113 out of 117 patients of the study population & only 4
(3.41%) patients were failed to be diagnosed by medical
thoracoscopy.
Other previous studies [14,15] showed that even after thora-
coscopy, around 10% of effusions remain undiagnosed. The
reasons for this false-negative thoracoscopy include insufﬁ-
cient and non-representative biopsies that depend largely on
the experience of the thoracoscopic [16] and the presence of
adhesions that prevent access to neoplastic tissues which often
are a consequence of repeated therapeutic thoracentesis [17].
Also the present study agreed with Venekamp et al. [18]
who retrospectively studied the natural evolution of 75patients between 1992 and 2002 who underwent diagnostic
thoracoscopy and in whom the histopathological diagnosis
of non-speciﬁc pleuritis was made. They tried to evaluate
whether the histological diagnosis of non-speciﬁc pleuritis cor-
responds with the clinical diagnosis of ‘‘idiopathic pleuritis’’
and they found that 8.3% of these 75 patients developed a
malignancy during the follow up period. In the remaining
patients (91.7%), the clinical evolution followed a benign
course.
The direct visualization of the pleural surface during med-
ical thoracoscopy is a major advantage which may help to sus-
pect a diagnosis and permit targeted biopsy from the abnormal
pleural regions with direct vision. In the present study, tho-
racoscopic ﬁndings included the presence of big pleural masses
in 23 patients (mainly in cases of mesothelioma), multiple var-
iable sized nodules in 67 patients (the largest nodules were in
metastatic adenocarcinoma and mesothelioma while the small-
est one or the sago grain appearance was in all cases of tuber-
culous pleurisy and sarcoidosis), septic pyogenic membranes
with extensive adhesions in 7 patients (mainly septic empy-
ema), diffuse pleural thickening in 17 patients (mainly meso-
thelioma followed by chronic non speciﬁc pleurisy) and
smooth apparently healthy pleura in 3 patients.
Prabhu and Narasimhan [19] studied 68 patients and found
nodules in 33 patients, adhesion in 26 patients and 8 patients
had sago grain appearance. When they compared these ﬁnd-
ings with the ﬁnal histopathological diagnosis, they reported
that 70% of patients who had nodules had malignant lesions
and 96% of patients who had adhesions had chronic or suba-
cute inﬂammation (non malignant lesion) and 100% of
patients who had sago grain appearance had tuberculosis.
Thoracocentesis was routinely performed to all patients in
this study to obtain pleural ﬂuid samples for biochemical
(including total protein, LDH, glucose and ADA) and cytolog-
ical analyses. Regarding chemical analysis of the pleural ﬂuid,
there was a statistically signiﬁcant difference between the histo-
pathological subgroups of the study population in the mean
values of LDH, glucose and ADA.
In this study, it was found that the mean value of glucose
level was signiﬁcantly lower in the septic empyema subgroup
when compared to chronic non speciﬁc pleurisy, lymphoma,
MPM and metastatic adenocarcinoma subgroups. Similarly,
Colice et al. [20] found that a pleural ﬂuid glucose concentra-
tion less than 60 mg/dl can be used to identify complicated
para-pneumonic effusions.
However, the mean value of LDH was signiﬁcantly higher
in septic empyema cases when compared to chronic non spe-
ciﬁc pleurisy, lymphoma, MPM and metastatic adenocarci-
noma subgroups. This agreed with Porcel et al. [21], who
found very high levels of pleural ﬂuid LDH in patients with
complicated para-pneumonic pleural effusion.
Pleural ﬂuid ADA can be a useful marker for diagnosis of
tuberculosis. Its sensitivity varies from 78% to 99% and its
speciﬁcity from 85% to 97% [22]. In the present study, the
mean value of ADA (38.8 IU/L) was signiﬁcantly higher in
cases of tuberculous pleurisy when compared to those of
MPM, metastatic adenocarcinoma, chronic non speciﬁc pleu-
risy and septic empyema histopathological subgroups. This
was in agreement with Verma et al. [23] (>36 IU/L), Niwa
et al. [24] (>38 IU/L) and Rodriquiz [25] (>37 IU/L) who
found higher levels of ADA in cases of tuberculous pleural
effusion.
Table 4 Smoking prevalence among histopathological subgroups of the study population.
Histopathological subgroups
Chronic non
speciﬁc pleurisy
Spindle cell
carcinoma
Lymphoma MPM Metastatic
adenocarcinoma
Sarcoidosis Septic
empyema
SLE T.B. pleurisy Total
Smokers Count 10 1 5 34 19 2 0 1 3 75
% within
histopathology
Subgroup
62.5 100 100.0 61.8 73.1 100.0 0.0 100.0 60.0 64.1
Non
smokers
Count 6 0 0 21 7 0 6 0 2 42
% within
histopathology
subgroup
37.5 0.0 0.0 38.2 26.9 0.0 100.0 0.0 40.0 35.9
Total Count 16 1 5 55 26 2 6 1 5 117
% within
histopathology
subgroup
100 100 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
P-value = 0.032*
Statistical signiﬁcance Signiﬁcant
* P-value < 0.05 means statistically signiﬁcant.
Table 5 Chemical analysis of the pleural ﬂuid among the histopathological subgroups of the study population.
Histopathological Subgroups Protein (g/dL)
(Mean ± SD)
LDH (IU/L)
(Mean ± SD)
Glucose (mg/dL)
(Mean ± SD)
ADA (IU/L)
(Mean ± SD)
Malignant pleural mesothelioma (N= 55) 5.02 ± 1.30 728.56 ± 474.87 82.84 ± 28.55 17.99 ± 9.51
Metastatic adenocarcinoma (N= 26) 4.61 ± 0.78 627.15 ± 483.82 98.58 ± 29.68 19.42 ± 9.34
Spindle cell carcinoma (N= 1) 2.90 844.00 83.00 10.00
Lymphoma (N= 5) 4.02 ± 1.01 557.20 ± 358.47 107.80 ± 77.31 17.60 ± 9.86
Tuberculous pleurisy (N= 5) 5.22 ± 0.52 675.80 ± 511.29 68.80 ± 13.03 38.80 ± 25.43
SLE (N= 1) 4.90 252.00 93.00 15.00
Sarcoidosis (N= 2) 4.55 ± 0.64 314.50 ± 91.22 70.00 ± 14.14 38.00 ± 24.04
Septic empyema (N= 6) 4.42 ± 0.63 2077.33 ± 2975.05 42.83 ± 23.79 13.83 ± 5.19
Chronic non speciﬁc pleurisy (N= 16) 4.86 ± 1.35 616.88 ± 466.94 80.06 ± 24.19 19.69 ± 15.33
Total (N= 117) 4.81 ± 1.15 740.18 ± 826.46 84.24 ± 32.55 19.45 ± 12.20
P-value 0.336 0.018* 0.010* 0.007*
Statistical signiﬁcance N.S. Sig. Sig. Sig.
* P-value < 0.05 means statistically signiﬁcant.
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only 5 cases were positive for malignant cells and then proved
by thoracoscopic pleural biopsy to be MPM and only 7 cases
showed atypical mesothelial cell and then proved to be MPM
(6 cases) and tuberculous pleurisy (1 case). The remaining 105
cases showed exudative effusion with no evidence of malignant
cells. On the other hand previous studies [17,26] showed that
cytological investigations of the pleural ﬂuid can reveal malig-
nancy in approximately 50–60% of the cases of malignant
pleural disease.
Pleural ﬂuid cytological analysis is critical in any patient
who had suspected malignancy or an exudative effusion of
unknown origin [27]. Several factors inﬂuence the diagnostic
potential of pleural ﬂuid cytology. The sensitivity of the pleu-
ral ﬂuid depends primarily upon the free-ﬂoating malignant
cells. These malignant cells have to be morphologically well
preserved with enough intact cytological features to be ﬁrst
diagnostic of malignancy and hopefully also diagnostic of aspeciﬁc malignant cell type [16]. These features, however,
may not be present, either with a malignancy that does not
shed off malignant cells into the pleural ﬂuid or a malignancy
that is largely necrotic and releases cells that are non-diagnos-
tic [16].
Medical thoracoscopy is a safe and easy procedure in
trained hands. Procedure related mortality is rare (0.24%,
which is comparable to that of bronchoscopic biopsy) in expe-
rienced hands [28]. Loddenkemper [2] reported that the most
serious, but rare complication is severe hemorrhage caused
by trauma to the blood vessel. Other reported complications
are empyema, prolonged air leakage, subcutaneous emphy-
sema, post procedure fever, wound infection, cardiac arrhyth-
mias, hypotension and seeding of the chest wall from
mesothelioma [29]. Overall, the side effects of medical thora-
coscopy appear to be few and it is extremely safe.
In the present study, there are no reported mortality and no
observed major complications, only 6 patients (5%) had minor
Table 6 Pattern of pleural ﬂuid cytology among histopathological subgroups of the study population.
Histopathological
subgroups
Chronic
non
speciﬁc
pleurisy
Spindle cell
carcinoma
Lymphoma MPM Metastatic
adenocarcinoma
Sarcoidosis Septic
empyema
SLE T.B. pleurisy Total
Atypical
mesothelial
cells
Count 0 0 0 6 0 0 0 0 1 7
% within
histopathology
subgroup
0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 20.0 6.0
Positive for
malignant cells
Count 0 0 0 5 0 0 0 0 0 5
within
histopathology
subgroup
0.0 0.0 0.0 47.3 0.0 0.0 0.0 0.0 0.0 4.3
No malignant
cells
Count 16 1 5 44 26 2 6 1 4 105
% within
histopathology
subgroup
100.0 100.0 100.0 80.0 100.0 100.0 100.0 100.0 80.0 11.1
Total Count 16 1 5 55 26 2 6 1 5 117
% within
histopathology
subgroup
100 100 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
P-value = 0.582
Statistical
signiﬁcance
904 S.A. Mohamed, M.M. Shabancomplications like prolonged air leak (1 patient), subcutaneous
emphysema (2 patients), wound infection (1 patient) and
empyema (2 patients).
Similarly, Mootha et al. [30] reported that out of 35 tho-
racoscopic procedures, 2 cases (5.2%) developed empyema
with no other complications. Also Prabhu and Narasimhan
[19] found that out of 68 patients who underwent medical tho-
racoscopy, there were no major complications, only 4 patients
had minor complications like subcutaneous emphysema (3
patients) and prolonged air leak (1 patient).
In conclusion, medical thoracoscopy is a valuable tool in
the diagnosis of undiagnosed pleural effusion. It is a simple
and safe method with a high diagnostic yield and lower com-
plication rates. Due to its higher diagnostic yield the future
of it is very bright.
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